When a patient is on daily antiviral pills due to Chronic Hepatitis B, the doctor measure the HBV DNA to see if the drug is working to reduce the viral load. The viral load varies over time depending upon patient’s age and the stage of hepatitis B.
Individuals with chronic hepatitis B (CHB) are at increased risk of developing liver cirrhosis, hepatic de-compensation and hepatocellular carcinoma. To maintain undetectable viral load reduces chronic infection complications.
The quantification range of this assay is 10 to 1,000,000,000 IU/mL (1.00 log to 9.00 log IU/mL).